The use of spinal cord stimulation in the treatment of comorbid patients with post-laminectomy syndrome and cardiovascular pathology

INTRODUCTION. In the treatment of patients with failed back surgery syndrome (FBSS), especially in older age groups burdened with concomitant multi-organ pathology, the method of spinal cord stimulation (SCS) is increasingly used.
AIM. To show the effect of spinal cord stimulation on pain syndrome and on cardiovascular function.
MATERIALS AND METHODS. The study included patients with chronic vertebrogenic pain syndrome who had previously undergone reconstructive surgery on the spine and had concomitant cardiovascular pathology that carries high surgical risks.
RESULTS. The obtained data demonstrated not only the neurological and analgesic effects of spinal cord stimulation, but also positive neuromodulatory effects on a number of important parameters of the cardiovascular system, such as the functional class of heart failure, heart rhythm disturbances, and pulmonary artery pressure.
CONCLUSION. SCS shows a high degree of effectiveness in achieving an analgesic effect, improving the quality and duration of life in patients with FBSS who are not considered candidates for repeated surgical intervention. This approach forms a new multidisciplinary principle of patient treatment with the participation of specialists in neurosurgery and cardiology.

1. Chan C. W., Peng P. Failed back surgery syndrome. Pain Med. 2011;(12):577–606.

2. Nachemson A. L. Evaluation of results in lumbar spine surgery. Acta Orthop Scand Suppl. 1993;(251):130–133.

3. Catheter Ablation vs Anti-arrhythmic Drug Therapy for Atrial Fibrillation Trial (CABANA). Thesis of HeartRhytm Congres. 2018. Available from: Acc.org/latest-in-cardiology/clinical-trials/2018/05/10/15/15/cabana#references-for-article [Accessed 15 October 2024].

4. Packer D. L., Mark D. B., Robb R. A. et al. Effect of Catheter Ablation vs Antiarrhythmic Drug Therapy on Mortality, Stroke, Bleeding, and Cardiac Arrest Among Patients With Atrial Fibrillation: The CABANA Randomized Clinical Trial. JAMA. 2019;321(13):1261–1274.

5. North R. B., Kidd D., Shipley J., Taylor R. S. Spinal cord stimulation versus reoperation for failed back surgery syndrome: a cost effectiveness and cost utility analysis based on a randomized, controlled trial. Neurosurgery. 2007;(61):361–368.

6. Mesa J., Yakovlev A. E.. Treatment of intractable angina pectoris utilizing spinal cord stimulation. Rev Cardiovac Med. 2008;9(1):70–74.

7. Yakovlev A. E., Yakovleva M. V., Chaykovskaya M. K., Ardashev A. V. The first in Russia experience of successful implementation of constant neurostimulation of the spinal cord in the complex treatment of a patient with permanent form of atrial fibrillation combined with spinal stenosis. Cardiology. 2019;59(9):83–90. (In Russ.).

8. Yakovlev A. E., Yakovleva M. V., Chaikovskaia M. K. Experience of clinical observation of patients with combined cardiological and neurological pathology: an innovative approach to the treatment of atrial fibrillation. Journal of Arrhythmology 2019;1(95):57–60. (In Russ.).

9. Romanov A., Lomivorotov V., Chernyavskiy A., Murtazin V., Kliver E., Ponomarev D., Mikheenko I., Yakovlev A., Yakovleva M., Steinberg J. Temporary Spinal Cord Stimulation to Prevent Postcardiac Surgery Atrial Fibrillation. J Am Coll Cardiol. 2022;79(7):754–756.

10. EFNS guidelines on neurostimulation therapy for neuropathic pain. European Journal of Neurology. 2007;(14):952–970.

11. Parati G., Esler M. The human sympathetic nervous system: its relevance in hypertension and heart failure. Eur Heart J. 2012;33(9):1058–1066.

12. Henderson J. M., Levy R. M. et al. NANS Training Requirements for Spinal Cord Stimulation Devices: Selection, Implatation and Fullow-up. Neuromodulation: Technology at the neural interface. 2009;12(3) :171–174. сThe DEFEAT-HF Study. Douglas P. Zipes, Petr Neuzil, Heinz Theres, David Caraway, PHD, Douglas L. Mann, Clas Mannheimer, Peter Van Buren, et al. JACC. Heart Failure. 2016;4(2).

13. Lopshire J. C., Zipes D. P. Device therapy to modulate the autonomic nervous system to treat heart failure. Curr Cardiol. Rep 2012;14(5):593–600.

14. Singh J. P., Kandala J., John Camm A. Nonpharmacological modulation of the autonomic tone to treat heart failure. Eur Heart J. 2014;35(2):77–85.

15. Zipes D. P., Rubart M. Neural modulation of cardiac arrhythmias and sudden cardiac death. Heart Rhythm. 2006;3(1):108–113.

16. Shen M. J., Choi E. K., Tan A. Y. et al. Neural mechanisms of atrial arrhythmias. Nat Rev Cardiol. 2012;9(1):30–39.

17. Yakovlev A. E., Yakovleva M. V. The use of spinal cord stimulation for the patient with ventricular arrhythmia, atrial fibrillation and pulmonary hypertension. Creative Cardiology. 2024;18(1):104–112.

18. Sousa-Pinto B., Ferreira-Pinto M. J., Santos M., LeiteMoreira A. F. Central nervous system circuits modified in heart failure: pathophysiology and therapeutic implications. Heart Fail Rev. 2014;19(6):759–779.

19. Takashi Kusayama et al. Neural Mechanisms and Therapeutic Opportunities for Atrial Fibrillation. Methodist Debakey Cardiovasc J. 2021;17(1):43–47.

20. Peter Hanna et al. Neuroscientific therapies for atrial fibrillation. ESC, Cardiovascular Research. 2021;(117):1732–1745.